Crescita Therapeutics Dividends
| CTX Stock | CAD 0.49 0.01 2.08% |
As of the 12th of February 2026, Dividend Paid And Capex Coverage Ratio is likely to grow to 2.17. Crescita Therapeutics' past performance could be the main factor of why investors trade Crescita Therapeutics stock today. Investors should clearly understand every aspect of the Crescita Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Crescita Therapeutics' dividend schedule and payout information. Crescita Therapeutics dividends can also provide a clue to the current valuation of Crescita Therapeutics.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | 2.07 | 2.17 |
Crescita |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Crescita Therapeutics must own a stock before its ex-dividend date to receive its next dividend.